573 related articles for article (PubMed ID: 25240644)
1. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
Takuma K; Hara Y; Kataoka S; Kawanai T; Maeda Y; Watanabe R; Takano E; Hayata-Takano A; Hashimoto H; Ago Y; Matsuda T
Pharmacol Biochem Behav; 2014 Nov; 126():43-9. PubMed ID: 25240644
[TBL] [Abstract][Full Text] [Related]
2. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
Yamaguchi H; Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Behav Brain Res; 2017 Aug; 333():67-73. PubMed ID: 28655565
[TBL] [Abstract][Full Text] [Related]
3. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid.
Kataoka S; Takuma K; Hara Y; Maeda Y; Ago Y; Matsuda T
Int J Neuropsychopharmacol; 2013 Feb; 16(1):91-103. PubMed ID: 22093185
[TBL] [Abstract][Full Text] [Related]
4. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Hara Y; Ago Y; Taruta A; Katashiba K; Hasebe S; Takano E; Onaka Y; Hashimoto H; Matsuda T; Takuma K
Autism Res; 2016 Sep; 9(9):926-39. PubMed ID: 26714434
[TBL] [Abstract][Full Text] [Related]
5. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Hara Y; Ago Y; Taruta A; Hasebe S; Kawase H; Tanabe W; Tsukada S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Psychopharmacology (Berl); 2017 Nov; 234(21):3217-3228. PubMed ID: 28798977
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism.
Hara Y; Ago Y; Higuchi M; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
Horm Behav; 2017 Nov; 96():130-136. PubMed ID: 28942000
[TBL] [Abstract][Full Text] [Related]
7. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
Raza S; Harker A; Richards S; Kolb B; Gibb R
Behav Brain Res; 2015 Apr; 282():25-36. PubMed ID: 25557797
[TBL] [Abstract][Full Text] [Related]
8. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
[TBL] [Abstract][Full Text] [Related]
9. mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model.
Kawase H; Ago Y; Naito M; Higuchi M; Hara Y; Hasebe S; Tsukada S; Kasai A; Nakazawa T; Mishina T; Kouji H; Takuma K; Hashimoto H
Pharmacol Biochem Behav; 2019 Jan; 176():1-5. PubMed ID: 30419271
[TBL] [Abstract][Full Text] [Related]
10. Pentyl-4-yn-VPA, a histone deacetylase inhibitor, ameliorates deficits in social behavior and cognition in a rodent model of autism spectrum disorders.
Foley AG; Cassidy AW; Regan CM
Eur J Pharmacol; 2014 Mar; 727():80-6. PubMed ID: 24486700
[TBL] [Abstract][Full Text] [Related]
11. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder.
Bringas ME; Carvajal-Flores FN; López-Ramírez TA; Atzori M; Flores G
Neuroscience; 2013 Jun; 241():170-87. PubMed ID: 23535253
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
[TBL] [Abstract][Full Text] [Related]
13. The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism.
Lima-Castañeda LÁ; Bringas ME; Aguilar-Hernandez L; Garcés-Ramírez L; Morales-Medina JC; Flores G
J Chem Neuroanat; 2023 Oct; 132():102317. PubMed ID: 37482145
[TBL] [Abstract][Full Text] [Related]
14. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
Codagnone MG; Podestá MF; Uccelli NA; Reinés A
Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
[TBL] [Abstract][Full Text] [Related]
15. In utero exposure to valproic acid and autism--a current review of clinical and animal studies.
Roullet FI; Lai JK; Foster JA
Neurotoxicol Teratol; 2013; 36():47-56. PubMed ID: 23395807
[TBL] [Abstract][Full Text] [Related]
16. Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice.
Yang EJ; Ahn S; Lee K; Mahmood U; Kim HS
PLoS One; 2016; 11(4):e0153298. PubMed ID: 27071011
[TBL] [Abstract][Full Text] [Related]
17. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
18. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice.
Moldrich RX; Leanage G; She D; Dolan-Evans E; Nelson M; Reza N; Reutens DC
Behav Brain Res; 2013 Nov; 257():253-64. PubMed ID: 24103642
[TBL] [Abstract][Full Text] [Related]
20. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
